MENU
STOK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Stoke Therapeutics (STOK) Ownership - Who owns Stoke Therapeutics?
Profile
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
618.65M
P/E Ratio
N/A
Total Cash
239.2M
Projected Growth
N/A
Total Debt
2.3M
Revenue
16.74M
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
4.52
Total Debt/Equity
N/A
Revenue/Share
0.33 USD as % of share price
Fundamentals
STOK
Capitalization
619M
P/E Ratio
N/A
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash
239M
Total Cash/Share
4.52
Total Debt
2.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.33%
Revenue
16.7M
ROE
N/A
Book Value
232M
P/B Ratio
2.67
Cash Flow
N/A
Earnings
-2.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
5.09
Current Revenue Per Employee
44490.91
Dividends Per Share - Security
N/A
EBITDA
-115.03M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-39.56
Shares Held By Institutions
792M
Shares Outstanding - Current
53M
Total Liabilities
61.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
122.053
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the research and development of treatments for genetic diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com